Send to printer »

GEN News Highlights : Dec 7, 2009

GenOway to Provide Beth Israel Deaconess Medical Center with Transgenic Rodents

genOway has been signed up to provide the Beth Israel Deaconess Medical Center (BIDMC) with genetically modified rodents for its medical research. The deal takes the form of a two-year, renewable-framework agreement.

genOway is a service provider dedicated to the development of genetically modified mouse and rat models. The company’s technologies include its Safe DNA Transgenesis™, Safe RNAi Transgenesis™, Safe in vivo RNAi™, and Quick Knock-in™ platforms.